Bernard Combe takes us through the findings from the FINCH 1 trial of filgotinib in rheumatoid arthritis patients with an inadequate response to methotrexate (7:19).
14-06-2019 | Rheumatoid arthritis | EULAR 2019 | Article
Bernard Combe takes us through the findings from the FINCH 1 trial of filgotinib in rheumatoid arthritis patients with an inadequate response to methotrexate (7:19).